A common first-line treatment approach for cryptococcal meningitis in low-income countries is being compromised by the emergence of drug resistance, new research warns. The findings highlight the need to develop new drugs and treatment regimens for the lethal brain infection, which kills around 180,000 people each year. https://www.sciencedaily.com/releases/2019/12/191206114607.htm
A research conducted by Giannis Daras and Alexandros G. Dimakis, both students at the University…
An international team of scientists has released the Hubble Space Telescope's largest near-infrared image ever.…
Getting advertised for your work or brand is an excellent way to gain the public’s…
CEO Dave McComb, President of Semantic Arts, noted during a talk in 2021 that one…
The answer is a resounding YES! Artificial Intelligence is a stream of work that requires high-level…
The Metaverse is a platform that sounds like a sci-fi concept, but shockingly, it’s as…